Thyroid Cancer

FDA Approves Selpercatinib for 3 RET-Positive Cancer Types
May 08, 2020

The FDA approved the first therapy to treat cancers with rearranged during transfection (RET) gene alterations.

Thyroid Cancer Review Summarizes Strategies for Treatment and Diagnosis
March 04, 2020

In a paper published in The BMJ, the authors provide a summary for the diagnosis, treatment, and monitoring of thyroid nodules.

Inaccurate Risk Perceptions Lead to Worry and Decreased QOL in Patients with Thyroid Cancer
January 29, 2020

The perceptions, which were associated with worry and a decreased quality of life, indicated the need for patient education that is suitable for diverse populations and improved risk communication by physicians.